menu search

BTAI / Why Shares of BioXcel Therapeutics Shot Up 25.4% This Week

Why Shares of BioXcel Therapeutics Shot Up 25.4% This Week
Investors may be anticipating a positive review by the FDA of the company's lead drug candidate. Read More
Posted: Mar 24 2022, 19:00
Author Name: The Motley Fool
Views: 103185

BTAI News  

4 Penny Stocks To Watch Today With Big News, Time To Buy?

By PennyStocks
October 30, 2023

4 Penny Stocks To Watch Today With Big News, Time To Buy?

Trading penny stocks can be a risky endeavor, but having access to quality news and information can help mitigate some of that risk. As an investor or more_horizontal

3 Penny Stocks To Buy For Under $5, Are They Worth It?

By PennyStocks
October 26, 2023

3 Penny Stocks To Buy For Under $5, Are They Worth It?

Penny stocks are defined as stocks trading for under $5. They typically include start-up or emerging-growth stage companies starting from the grassroo more_horizontal

Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?

By InvestorPlace
October 25, 2023

Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?

BioXcel Therapeutics (NASDAQ: BTAI ) stock is rocketing higher on Wednesday after the biopharmaceutical company announced results from an audit of its more_horizontal

BioXcel Therapeutics shares pop after audit of Alzheimer's trial data

By Market Watch
October 25, 2023

BioXcel Therapeutics shares pop after audit of Alzheimer's trial data

Shares of BioXcel Therapeutics Inc. BTAI, +0.86% jumped more than 40% premarket on Wednesday after the company said an independent audit of Alzheimer' more_horizontal

Why Shares of BioXcel Therapeutics Fell This Week

By The Motley Fool
September 28, 2023

Why Shares of BioXcel Therapeutics Fell This Week

The company has one marketed treatment -- Igalmi, which reduces agitation in patients with bipolar disorder or schizophrenia. The most advanced candid more_horizontal

Why BioXcel Therapeutics Stock Flopped Again Today

By The Motley Fool
August 15, 2023

Why BioXcel Therapeutics Stock Flopped Again Today

The biotech takes another hit following its earnings release on Monday. Several analysts became notably more bullish on its prospects. more_horizontal

3 Biotech Stocks to Sell in August Before They Crash and Burn

By InvestorPlace
August 14, 2023

3 Biotech Stocks to Sell in August Before They Crash and Burn

Investors who've dipped their toe into the waters of biotech stocks know that the chances of these stocks crashing and burning is certainly higher tha more_horizontal

Why BioXcel Therapeutics Stock Is Getting Crushed Today

By The Motley Fool
August 14, 2023

Why BioXcel Therapeutics Stock Is Getting Crushed Today

BioXcel announced Q2 results and a major strategic shift this morning. The biotech specialist has halted plans for Phase 2 clinical trials that were i more_horizontal


Search within

Pages Search Results: